Report an error   


Submitted: 18 August 2017 Modified: 18 August 2017
HERDIN Record #: NCR-JAFES-17081716393121

The Asia-Pacific region carries a high disease burden, with over half of the global diabetic population residing in this region. Increasing evidence shows that without targeted intervention, the progression from impaired glucose tolerance (IGT) to type 2 diabetes occurs more frequently in Asians compared with Caucasians. Furthermore, IGT is independently associated with an increased risk of cardiovascular disease, and should be managed as early as possible. Because diabetes is now a major public health issue, strategies aimed at prevention and treatment are urgently required. Lifestyle modification, including weight loss, dietary changes and increased physical activity, play a major role in controlling the disease. Significant evidence also supports the effectiveness of a combination of lifestyle modification and pharmacologic therapy, such as metformin, in delaying the onset of diabetes. Although the importance of lifestyle interventions is well recognized throughout Asia, many countries do not have formal recommendations to guide the diagnosis and management of individuals at risk of progression to diabetes. At a recent regional meeting, experts from the Asian region convened to develop consensus recommendations to guide clinicians in the management of Asian patients with pre-diabetes. These consensus recommendations provide a clear and concise approach to the management of individuals with IGT based on the available evidence and current best clinical practice.

Publication Type
Journal
Publication Sub Type
Feature Article
Title
Journal of the ASEAN Federation of Endocrine Societies
Frequency
Semi-Annual
Publication Date
May-October 2017
Volume
32
Issue
1
Page(s)
6-12
LocationLocation CodeAvailable FormatAvailability
http://www.asean-endocrinejournal.org (632) 6373162 Fulltext External Link (View)
1. (2013, November 30). Diabetes Atlas 6th edition poster update. International Diabetes Federation.
2. Ramachandran, A , Snehalatha, C , Ma, RC . "Diabetes in South-East Asia: an update" Diabetes Res Clin Pract 103(2): 231-7, 2014
3. Wan Nazaimoon, WM , Md Isa, SH , Mohamad, WB . "Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion" Diabet Med 30(7): 825-8, 2013
4. Geiss, LS , Gregg, EW , Albright, A , Williamson, DF , Cowie, CC . "Diabetes risk reduction behaviors among U.S. adults with prediabetes" Am J Prev Med 38(4): 403-9, 2010
5. Mustafa, N , Kamarudin, NA , Ismail, AA . "Prevalence of abnormal glucose tolerance and risk factors in urban and rural Malaysia" Diabetes Care 34(6): 136204, 2011
6. Garber, AJ , Abrahamson , MJ , Barzilay , JI . "Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2016 Executive Summary" Endocr Pract 22(1): 84-113, 2016
7. Mata-Cases, M , Artola , S , Escalada, J . "Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society" Rev Clin Esp 215(2): 117-29, 2015
8. Yan, ST , Hiao, HY , Tian, H . "The cutoffs and performance of glycated hemoglobin for diagnosing diabetes and prediabetes in a young and middle-aged population and in an elderly population" Diabetes Res Clin Pract 109(2): 238-45, 2015
9. Akter, S , Rahman, MM , Abe, SK , Sultana, P . "Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey" Bull World Health Organ 92(3): 204-14, 21, 2014
10. Mayega, RW , Guwatudde, D , Makumbi , F . "Diabetes and pre-diabetes among persons aged 35 to 60 years in eastern Uganda: Prevalence and associated factors" PLoS One 8(8): e72554, 2013
11. Zhuo , X , Zhang, P , Selvin, E . "Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective" Am J Prev Med 42(4): 374-81, 2012
12. "American Diabetes Association. Standards of Medical Care in Diabetes—2015" Diabetes Care 38(Suppl 1): S1-89, 2015
13. International Diabetes Federation Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels, Belgium: International Diabetes Federation, 2012.
14. Clinical practice guidelines—Management of type 2 diabetes mellitus, 5th ed. Putrajaya, Malaysia: Ministry of Health Malaysia, 2015.
15. "Diabetes Mellitus—MOH Clinical Practice Guidelines 1/2014" 2014. Singapore: Ministry of Health Singapore,
16. Task Force on Conceptual Model and Preventive Protocols, Working Group on Primary Care, Food and Health Bureau. Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings. Hong Kong: 2013.
17. Buku Panduan - Pengurus Besar Persatuan Diabetes Indonesia. Indonesia: PB Persadia, 2009.
18. Bansal, N . "rediabetes diagnosis and treatment: A review" World J Diabetes 6(2): 6-303, 2015
19. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva, Switzerland: World Health Organization, 2006.
20. Pan, XR , Li, GW , Hu, YU . "Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study" Diabetes Care 20(4): 537-44, 1997
21. Ramachandran, A , Snehalatha, C , Mary, S . "The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)" Diabetologia 49(2): 289-97, 2006
22. Tuomilehto, J , Lindström, J , Eriksson, JG . "Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance" N Engl J Med 344(18): 1343-50, 2001
23. Knowler, WC , Barrett-Connor, E , Fowler, SE . "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin" N Engl J Med 346(6): 393-403, 2002
24. IDF Diabetes Atlas, 6th edition. Brussels, Belgium: International Diabetes Federation, 2013.

Copyright © One Window Project 2018. All rights reserved.